Open Access
VIEWPOINT
Inflammatory priming of mesenchymal stem cells: Focus on growth factors enhancement
ALEKSANDRA GORNOSTAEVA, ELENA ANDREEVA*, LUDMILA BURAVKOVA*
Cell Physiology Laboratory, Institute of Biomedical Problems of Russian Academy of Sciences, Moscow, 123007, Russia
* Corresponding Authors: Elena Andreeva, ; Ludmila Buravkova,
(This article belongs to the Special Issue: Mesenchymal Stem Cells, Secretome and Biomaterials: Regenerative Medicine Application)
BIOCELL 2022, 46(9), 2049-2052. https://doi.org/10.32604/biocell.2022.019993
Received 28 October 2021; Accepted 17 January 2022; Issue published 18 May 2022
Abstract
Multipotent mesenchymal stromal cells (MSCs) are actively involved in reparation and inflammation processes,
providing damaged tissue reparation and suppressing immune cell responses in vivo. The effects are mostly due to the
production of a wide range of paracrine factors, including growth factors and immunomodulatory mediators. To induce
immunosuppressive activity, MSCs are primed by inflammatory cytokines, which results in an increased production of
immunomodulatory molecules. However, stimulation of reparative properties is also necessary. This viewpoint
manuscript highlights the possibilities of inflammatory priming to increase the production of growth factors by MSCs.
Keywords
Cite This Article
APA Style
GORNOSTAEVA, A., ANDREEVA, E., BURAVKOVA, L. (2022). Inflammatory priming of mesenchymal stem cells: focus on growth factors enhancement. BIOCELL, 46(9), 2049-2052. https://doi.org/10.32604/biocell.2022.019993
Vancouver Style
GORNOSTAEVA A, ANDREEVA E, BURAVKOVA L. Inflammatory priming of mesenchymal stem cells: focus on growth factors enhancement. BIOCELL . 2022;46(9):2049-2052 https://doi.org/10.32604/biocell.2022.019993
IEEE Style
A. GORNOSTAEVA, E. ANDREEVA, and L. BURAVKOVA "Inflammatory priming of mesenchymal stem cells: Focus on growth factors enhancement," BIOCELL , vol. 46, no. 9, pp. 2049-2052. 2022. https://doi.org/10.32604/biocell.2022.019993